ストックスクリーナーアプリを入手
1.13
35.06%
-0.61
Inovio Pharmaceuticals Inc (INO) 最新ニュース
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
INO FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO - GlobeNewswire Inc.
ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
Inovio Pharmaceuticals stock tumbles on dilutive offering By Investing.com - Investing.com Canada
Inovio Pharmaceuticals stock tumbles on dilutive offering - Investing.com
Inovio Plummets 34.5%: Biotech's Volatile Move Sparks Market Alert - Bitget
What's Behind The Drop In Inovio Pharmaceuticals Stock Today? - Benzinga
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) ... - Bluefield Daily Telegraph
Inovio Faces New SEC Scrutiny Amidst Stock Sale Plans - stockstotrade.com
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain OfficersINO - PR Newswire
Inovio announces pricing of $17.5 million public offering - MarketScreener
Inovio prices $17.5 million public offering of shares and warrants - MSN
Inovio prices $17.5M stock offering with warrants - Investing.com
INOVIO sells 12.5M shares and warrants in $17.5M financing - Stock Titan
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program - TipRanks
[424B5] INOVIO PHARMACEUTICALS, INC. Prospectus Supplement (Debt Securities) - Stock Titan
Inovio Pharmaceuticals suspends at-the-market offering prospectus - investing.com
According to the latest filings from the US Securities and Exchange Commission (SEC), biotechnology company Inovio Pharmaceuticals has officially suspended and terminated its at-the-market (ATM) equity offering prospectus previously established with inve - Bitget
Inovio suspends ATM prospectus after $3.2M sold under program - TradingView
Inovio (NASDAQ: INO) suspends ATM prospectus after selling 1.32M shares - Stock Titan
Inovio Pharmaceuticals proposes securities offering - MSN
Biotech INOVIO seeks buyers for stock plus two warrant series - Stock Titan
INOVIO to Participate in Upcoming Scientific Conference - Sahm
Inovio announces proposed public offering of stock and warrants By Investing.com - Investing.com Canada
INOVIO Announces Proposed Public Offering - PR Newswire
INOVIO (NASDAQ: INO) CMO converts RSUs; 1,223 shares withheld for taxes - Stock Titan
INOVIO to show mouse hemophilia treatment data on April 22 - Stock Titan
Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2026 to Discuss Your RightsINO - PR Newswire
INO SEC FilingsInovio Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO - ChartMill
Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors - GlobeNewswire
INO Stock Price, Quote & Chart | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill
Inovio Pharmaceuticals Faces Investor Deadline - National Today
Volume Summary: Is Inovio Pharmaceuticals Inc a top pick in the sectorWeekly Trend Report & Smart Investment Allocation Tips - baoquankhu1.vn
INOVIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, - GlobeNewswire
Levi & Korsinsky Reminds Inovio Pharmaceuticals, Inc. - GlobeNewswire
Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Inovio - GlobeNewswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
INO STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmace - GuruFocus
INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026 - ChartMill
Aug Fed Impact: Whats the MACD signal for Inovio Pharmaceuticals Inc2026 PreEarnings & Weekly Return Optimization Plans - baoquankhu1.vn
INO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors ... - Caledonian Record
KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate - The Globe and Mail
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire
INO Shareholder Alert: Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit Investors ... - Bluefield Daily Telegraph
INO Shareholder Alert: Inovio Pharmaceuticals, Inc. - GlobeNewswire
SRPT Stock Surges on Promising Early Results From siRNA Programs - The Globe and Mail
BEAM Eyes Global Expansion of AATD Study After Strong Early Data - The Globe and Mail
Market Overview: How correlated is Inovio Pharmaceuticals Inc to the S P5002026 Update & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Inovio Q4 2025 slides: BLA accepted but FDA questions linger By Investing.com - Investing.com Canada
0.49%
1.47%
大文字化:
|
ボリューム (24 時間):